Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-10-12 Sale |
2020-10-13 5:52 pm |
NGM BIOPHARMACEUTICALS INC | NGM | CHEN JIN-LONG Chief Scientific Officer |
25,000 | $17.02 | $425,500 | 945,005 (Direct) |
View |
| 2020-09-01 Purchase |
2020-09-03 5:32 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP Svennilson Peter GOEDDEL DAVID V Director 10% Owner |
64,089 | $17.65 | $1,131,358 | 18,242,932 (Indirect Direct) |
View |
| 2020-09-01 Purchase |
2020-09-03 5:31 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP II LP Column Group II GP LP Column Group Management LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim Director 10% Owner |
64,089 | $17.65 | $1,131,358 | 18,242,932 (Indirect Direct) |
View |
| 2020-09-01 Sale |
2020-09-03 4:18 pm |
NGM BIOPHARMACEUTICALS INC | NGM | CHEN JIN-LONG Chief Scientific Officer |
25,000 | $17.83 | $445,829 | 970,005 (Direct) |
View |
| 2020-08-27 Purchase |
2020-08-31 5:02 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner |
62,494 | $17.83 | $1,114,382 | 18,178,843 (Indirect Direct) |
View |
| 2020-08-27 Purchase |
2020-08-31 5:00 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP II LP Column Group II GP LP Column Group Management LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim Director 10% Owner |
62,494 | $17.83 | $1,114,382 | 18,178,843 (Indirect Direct) |
View |
| 2020-08-21 Purchase |
2020-08-25 6:50 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner |
18,445 | $17.96 | $331,349 | 18,116,349 (Indirect Direct) |
View |
| 2020-08-21 Purchase |
2020-08-25 6:50 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP II LP Column Group II GP LP Column Group Management LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim Director 10% Owner |
18,445 | $17.96 | $331,349 | 18,116,349 (Indirect Direct) |
View |
| 2020-08-13 Purchase |
2020-08-17 7:12 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner |
64,313 | $17.65 | $1,135,362 | 18,097,904 (Indirect Direct) |
View |
| 2020-08-13 Purchase |
2020-08-17 7:11 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP II LP Column Group II GP LP Column Group Management LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim Director 10% Owner |
64,313 | $17.65 | $1,135,362 | 18,097,904 (Indirect Direct) |
View |
| 2020-08-10 Sale |
2020-08-11 4:30 pm |
NGM BIOPHARMACEUTICALS INC | NGM | CHEN JIN-LONG Chief Scientific Officer |
25,000 | $19.02 | $475,500 | 995,005 (Direct) |
View |
| 2020-07-30 Purchase |
2020-08-03 5:57 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner |
732 | $17.99 | $13,169 | 18,033,591 (Indirect Direct) |
View |
| 2020-07-30 Purchase |
2020-08-03 5:54 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP II LP COLUMN GROUP GP LP Column Group Management LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim Column Group II GP LP Director 10% Owner |
732 | $17.99 | $13,169 | 18,033,591 (Indirect Direct) |
View |
| 2020-07-28 Purchase |
2020-07-30 8:08 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner |
4,105 | $17.99 | $73,849 | 18,032,859 (Indirect Direct) |
View |
| 2020-07-28 Purchase |
2020-07-30 7:23 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP II LP COLUMN GROUP GP LP Column Group Management LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim Column Group II GP LP Director 10% Owner |
4,105 | $17.99 | $73,849 | 18,032,859 (Indirect Direct) |
View |
| 2020-07-24 Purchase |
2020-07-28 5:40 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP GOEDDEL DAVID V Svennilson Peter Director 10% Owner |
72,583 | $17.93 | $1,301,643 | 18,028,754 (Indirect Direct) |
View |
| 2020-07-24 Purchase |
2020-07-28 5:39 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP II LP COLUMN GROUP GP LP Column Group Management LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim Column Group II GP LP Director 10% Owner |
72,583 | $17.93 | $1,301,643 | 18,028,754 (Indirect Direct) |
View |
| 2020-07-22 Purchase |
2020-07-23 5:44 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Ponoi Capital II LP Ponoi II Management LLC Svennilson Peter Kutzkey Tim GOEDDEL DAVID V Director 10% Owner |
193 | $18 | $3,474 | 17,976,977 (Indirect Direct) |
View |
| 2020-07-22 Purchase |
2020-07-23 5:39 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP II LP COLUMN GROUP GP LP Column Group II GP LP Column Group Management LP COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP Ponoi Management LLC PONOI CAPITAL LP Director 10% Owner |
193 | $18 | $3,474 | 17,976,977 (Indirect Direct) |
View |
| 2020-07-01 Sale |
2020-07-02 4:36 pm |
NGM BIOPHARMACEUTICALS INC | NGM | CHEN JIN-LONG Chief Scientific Officer |
25,000 | $18.91 | $472,728 | 1,020,005 (Direct) |
View |
| 2020-06-15 Sale |
2020-06-17 6:31 pm |
NGM BIOPHARMACEUTICALS INC | NGM | CHEN JIN-LONG Chief Scientific Officer |
25,000 | $21.65 | $541,166 | 1,045,005 (Direct) |
View |
| 2020-05-15 Sale |
2020-05-18 4:35 pm |
NGM BIOPHARMACEUTICALS INC | NGM | Lieu Hsiao D SVP, Chief Medical Officer |
1,562 | $22 | $34,364 | 182 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-05-15 Option Award |
2020-07-23 5:44 pm |
2020-05-15 2029-05-14 |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Ponoi Capital II LP Ponoi II Management LLC Svennilson Peter Kutzkey Tim GOEDDEL DAVID V Director 10% Owner |
64,806 | $0 | 17,976,977 (Indirect) |
View |
| 2020-07-21 Exercise |
2020-07-23 5:44 pm |
2020-05-15 2020-08-18 |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Ponoi Capital II LP Ponoi II Management LLC Svennilson Peter Kutzkey Tim GOEDDEL DAVID V Director 10% Owner |
24,000 | $0 | 17,976,977 (Direct) |
View |
| 2020-07-21 Exercise |
2020-07-23 5:44 pm |
N/A N/A |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P Ponoi Capital II LP Ponoi II Management LLC Svennilson Peter Kutzkey Tim GOEDDEL DAVID V Director 10% Owner |
24,000 | $13.35 | 17,976,977 (Direct) |
View |
| 2019-05-15 Option Award |
2020-07-23 5:39 pm |
2020-05-15 2029-05-14 |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP II LP COLUMN GROUP GP LP Column Group II GP LP Column Group Management LP COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP Ponoi Management LLC PONOI CAPITAL LP Director 10% Owner |
64,806 | $0 | 17,976,977 (Indirect) |
View |
| 2020-07-21 Exercise |
2020-07-23 5:39 pm |
2020-05-15 2020-08-18 |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP II LP COLUMN GROUP GP LP Column Group II GP LP Column Group Management LP COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP Ponoi Management LLC PONOI CAPITAL LP Director 10% Owner |
24,000 | $0 | 17,976,977 (Direct) |
View |
| 2020-07-21 Exercise |
2020-07-23 5:39 pm |
N/A N/A |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P COLUMN GROUP II LP COLUMN GROUP GP LP Column Group II GP LP Column Group Management LP COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP Ponoi Management LLC PONOI CAPITAL LP Director 10% Owner |
24,000 | $13.35 | 17,976,977 (Direct) |
View |
Ownership |
2020-07-15 9:55 pm |
N/A N/A |
NGM BIOPHARMACEUTICALS INC | NGM | Nolan Mangini Siobhan Chief Financial Officer |
0 | $0 | 0 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-09 5:08 pm |
N/A 2030-06-04 |
NGM BIOPHARMACEUTICALS INC | NGM | Ho Carole Director |
39,515 | $0 | 39,515 (Direct) |
View |
Ownership |
2020-06-09 5:05 pm |
N/A N/A |
NGM BIOPHARMACEUTICALS INC | NGM | Ho Carole Director |
0 | $0 | 0 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 6:47 pm |
N/A 2030-05-19 |
NGM BIOPHARMACEUTICALS INC | NGM | Hooper Suzanne Sawochka Director |
16,806 | $0 | 16,806 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 6:44 pm |
N/A 2030-05-19 |
NGM BIOPHARMACEUTICALS INC | NGM | TICHENOR MCHENRY T Director |
16,806 | $0 | 16,806 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 6:42 pm |
N/A 2030-05-19 |
NGM BIOPHARMACEUTICALS INC | NGM | SCHNELL DAVID Director |
16,806 | $0 | 16,806 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 6:37 pm |
N/A 2030-05-19 |
NGM BIOPHARMACEUTICALS INC | NGM | LESCHLY MARK Director |
16,806 | $0 | 16,806 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 6:36 pm |
N/A 2030-05-19 |
NGM BIOPHARMACEUTICALS INC | NGM | Guyer Shelly D Director |
16,806 | $0 | 16,806 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 6:35 pm |
N/A 2030-05-19 |
NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner |
16,806 | $0 | 16,806 (Direct) |
View |